Table 6.
Comparison of comprehensive examinations with SVS test.
| SPVAC-P/SVS-F group #1 (eyes) |
SPVAC-F/SVS-P group #2 (eyes) |
SPVAC-F/SVS-F group #3 (eyes) |
P-value | |
|---|---|---|---|---|
| SVS success numbers | 150 | 28 | 74 | |
| Normal | 54/150 (36.0%) | 24/28 (86.0%) | 10/74 (13.5%) | *#1 vs #2 <.001 *#1 vs #3 <.001 *#2 vs #3 <.001 |
| Treatment needed | 86/150 (57.3%) | 2/28 (7.0%) | 60/74 (81.3%) | |
| Hyperopia, Astigmatism, Myopia | 10 | 2 | 12 | |
| Ametropic amblyopia | 56 | 0 | 37 |
†SVS pass group vs SVS no pass group (#2 vs #1 + #3) <.001 |
| Anisometropic amblyopia | 8 | 0 | 11 | |
| Esotropia/esophoria | ||||
| Exotropia/exophoria | ||||
| Oblique muscle dysfunctions | 12 | 0 | 0 | |
| Diagnosis is impossible | 10/150 (6.7%) | 2/28 (7.0%) | 4/7 (5.4%) |
F = fail, P = pass, SPVAC = single-picture optotype visual acuity chart, SVS = Spot™ Vision Screener.
*Fishers exact test with Bonferroni correction.
†
Fishers exact test.